Terms: = Endocrine gland cancer AND HOXD11, ENSG00000128713, 3237 AND Treatment
4 results:
1. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract] [Full Text] [Related]
2. A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
Cohen EE; Tortorici M; Kim S; Ingrosso A; Pithavala YK; Bycott P
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1261-70. PubMed ID: 25315258
[TBL] [Abstract] [Full Text] [Related]
3. Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma.
Giovinazzo F; Butturini G; Monsellato D; Malleo G; Marchegiani G; Bassi C
Updates Surg; 2013 Mar; 65(1):19-24. PubMed ID: 23417896
[TBL] [Abstract] [Full Text] [Related]
4. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract] [Full Text] [Related]
